How does Gastroesophageal Reflux Disease (GERD) affect constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Relationship Between GERD and Constipation

GERD and constipation have a bidirectional relationship, with treatment of constipation often improving GERD symptoms, as constipation can exacerbate reflux through increased intra-abdominal pressure. 1, 2

Pathophysiological Connection

GERD and constipation frequently coexist, with research showing significantly higher rates of laxative use among GERD patients (38.1%) compared to non-GERD patients (21.3%) 1. This connection can be explained through several mechanisms:

  • Increased intra-abdominal pressure: Constipation causes stool accumulation in the colon, increasing intra-abdominal pressure which can push stomach contents upward, worsening reflux
  • Shared motility disorders: Both conditions may stem from underlying gastrointestinal motility problems
  • Medication side effects: Some GERD medications, particularly proton pump inhibitors, may contribute to constipation 3

Clinical Evidence of the Connection

The relationship between GERD and constipation is supported by several key findings:

  • In pediatric patients with functional constipation and GERD, treatment of constipation led to significant improvement in acid reflux index and GERD symptoms 2
  • A study comparing Psyllium seed treatment (which addresses constipation) with omeprazole for GERD found that while both treatments were initially effective (89.2% vs 94% response rates), the Psyllium group had significantly lower recurrence of GERD symptoms (24.1% vs 69.8%) 4
  • Constipation is one of the most commonly reported treatment-related adverse reactions in pediatric patients taking lansoprazole for GERD (5% in children aged 1-11 years) 3

Management Implications

Understanding this relationship has important clinical implications:

  1. Assess for constipation in GERD patients:

    • Particularly important in patients with refractory GERD not responding to standard PPI therapy 5
    • Essential in pediatric populations where both conditions frequently coexist 6, 2
  2. Consider treating constipation as part of GERD management:

    • Fiber supplementation (e.g., Psyllium) may help manage both conditions simultaneously 4
    • Address lifestyle factors that impact both conditions:
      • Weight management for overweight/obese patients 7
      • Dietary modifications including adequate fiber and fluid intake
      • Regular physical activity
  3. Monitor for constipation when prescribing GERD medications:

    • PPIs like lansoprazole can cause constipation, particularly in pediatric patients 3
    • Consider alternative medications or add preventive measures if constipation is already present

Special Considerations

  • Pediatric patients: The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines emphasize distinguishing between physiologic GER and pathologic GERD in children 6. Constipation should be addressed as a potential contributing factor to GERD symptoms.

  • Refractory GERD: In patients with partial or no response to PPI therapy, evaluation for constipation and other contributing factors is essential before considering surgical or endoscopic interventions 5.

  • Patient education: As recommended by the American Gastroenterological Association, providing standardized educational material on GERD mechanisms and lifestyle modifications is essential 6, 7. This should include information about the potential impact of constipation on GERD symptoms.

By recognizing and addressing the relationship between GERD and constipation, clinicians can provide more effective management for both conditions and improve patient outcomes.

References

Research

Refractory gastroesophageal reflux disease.

Gastroenterology report, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gastroesophageal Reflux Disease Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.